Skip to main content

Graetz Wealth LLC

SEC CIK
0002053877
Latest filing
Aug 13, 2026

HALO holding history

Halozyme Therapeutics, Inc. in every 13F filed by Graetz Wealth LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

HALO overviewAll 13F holders of HALOFull Q2 2026 holdings

Shares (Q2 2026)
3,708
Value
$290.2K
% of portfolio
0.2%
Quarters held
2
Since Q1 2026
Holdings of HALO by Graetz Wealth LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20263,708$290.2K0.2%+140+3.9%AddedHolders
Q1 20263,568$230.6K0.2%+3,568NewHolders